Listening...

Search Results

No Results

    See all results

    Sorry, I don't understand. Please try again
    1. United States/
    2. ERLEADA® (apalutamide), First-and-Only Next-Generation Androgen Receptor Inhibitor with Once-Daily, Single-Tablet Option, Now Available in the U.S.

    ERLEADA® (apalutamide), First-and-Only Next-Generation Androgen Receptor Inhibitor with Once-Daily, Single-Tablet Option, Now Available in the U.S.

    April 3, 2023
    April 3, 2023

    Download the PDF